SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-009732
Filing Date
2017-09-15
Accepted
2017-09-15 16:03:23
Documents
6
Period of Report
2017-09-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k091517_biondvaxpharma.htm 6-K 23828
2 UNDERWRITING AGREEMENT DATED SEPTEMBER 13, 2017 f6k091517ex1-1_biondvaxphar.htm EX-1.1 270274
3 OPINION OF PEARL COHEN ZEDEK LATZER BARATZ f6k091517ex5-1_biondvaxphar.htm EX-5.1 13865
4 OPINION OF PEARL COHEN ZEDEK LATZER BARATZ, LLP f6k091517ex5-2_biondvaxphar.htm EX-5.2 17384
5 GRAPHIC ex5-1_001.jpg GRAPHIC 9086
6 GRAPHIC ex5-2_001.jpg GRAPHIC 6235
  Complete submission text file 0001213900-17-009732.txt   347723
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 171088014
SIC: 2836 Biological Products, (No Diagnostic Substances)